Patents by Inventor Boris Guiu

Boris Guiu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lipiodol-based anti-tumour emulsion for treating cancer
    Patent number: 10064883
    Abstract: The present invention relates to a pharmaceutical composition including Lipiodol and a molecule with anti-tumor activity and secondarily a hydroxyethyl starch. The present invention also relates to the use of the compositions according to the invention for treating cancer. According to one embodiment, the pharmaceutical composition according to the invention has between 0.004% and 0.2% by weight of idarubicin, between 0.38% and 2.25% by weight of hydroxyethyl starch and secondarily between 60% and 68% by weight of Lipiodol, and water for injection (or even physiological saline) in a quantity sufficient (q.s.) for 100%.
    Type: Grant
    Filed: July 5, 2013
    Date of Patent: September 4, 2018
    Assignee: GUERBET
    Inventors: Boris Guiu, Mathieu Boulin, Jean-Pierre Cercueil
  • LIPIODOL-BASED ANTI-TUMOUR EMULSION FOR TREATING CANCER
    Publication number: 20150265640
    Abstract: The present invention relates to a pharmaceutical composition including Lipiodol and a molecule with anti-tumour activity and secondarily a hydroxyethyl starch. The present invention also relates to the use of the compositions according to the invention for treating cancer. According to one embodiment, the pharmaceutical composition according to the invention has between 0.004% and 0.2% by weight of idarubicin, between 0.38% and 2.25% by weight of hydroxyethyl starch and secondarily between 60% and 68% by weight of Lipiodol, and water for injection (or even physiological saline) in a quantity sufficient (q.s.) for 100%.
    Type: Application
    Filed: July 5, 2013
    Publication date: September 24, 2015
    Applicants: UNIVERSITE DE BOURGOGNE, CHU DE DIJON
    Inventors: Boris Guiu, Mathieu Boulin, Jean-Pierre Cercueil